Literature DB >> 10987935

A convenient synthesis and spectroscopic characterization of N, N'-Bis(2-propenyl)-2,7-diazapyrenium quaternary salts

.   

Abstract

N,N'-Bis(2-propenyl)-2,7-diazapyrenium salts are synthesized in good yield from the reaction of 1,4,5,8-naphthalenetetracarboxylic dianhydride with allylamine, followed by LiAlH(4) reduction and subsequent oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). The nature of the counteranion depends on the solvent system used for recrystallization of the crude product from the final DDQ-oxidation step. X-ray analysis shows that if recrystallization is carried out in boiling CH(3)OH/H(2)O (1:1, v/v), the counteranion in the resulting deep-red crystals is always the alkoxy anion of 2-cyano-5,6-dichloro-3-hydroxy-1,4-benzoquinone, whether the final DDQ oxidation ends with addition of HClO(4) or HCl; on the other hand, if recrystallization is carried out with anhydrous acetonitrile, the product is N,N'-bis(2-propenyl)-2,7-diazapyrenium diperchlorate or dichloride depending on whether the DDQ oxidation is followed by addition of concd HClO(4) or concd HCl, respectively. Importantly, if the DDQ oxidation is quenched with HBr, Br(-) is oxidized to Br(2) by unreacted DDQ, and the resulting product is N, N'-bis(2,3-dibromopropyl)-2,7-diazapyrenium dibromide. Comparative absorption and time-resolved emission studies provide evidence for possible dimerization of N,N'-bis(2-propenyl)-2,7-diazapyrenium diperchlorate in CH(3)CN.

Entities:  

Year:  2000        PMID: 10987935     DOI: 10.1021/jo0004557

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  1 in total

Review 1.  2,7-Diazapyrenes: a brief review on synthetic strategies and application opportunities.

Authors:  Anindita Mukherjee; Alexey A Akulov; Sougata Santra; Mikhail V Varaksin; Grigory A Kim; Dmitry S Kopchuk; Olga S Taniya; Grigory V Zyryanov; Oleg N Chupakhin
Journal:  RSC Adv       Date:  2022-03-24       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.